CSF Synaptic Biomarkers in AT(N)-Based Subgroups of Lewy Body Disease.
Lorenzo BarbaSamir Abu-RumeilehSteffen HalbgebauerGiovanni BellomoFederico Paolini PaolettiLorenzo GaetaniPatrick OecklPetra SteinackerFederico MassaLucilla ParnettiMarkus OttoPublished in: Neurology (2023)
This study provides Class II evidence that CSF levels of β-synuclein, α-synuclein, SNAP-25, neurogranin and NfL are higher in patients with AD than in patients with LBD.
Keyphrases